HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels

Clinica Chimica Acta

Volumn 389, Issue 1-2, 2008, Pages 164-166

  Bergström, Jonas P ^a   Helander, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcohol biomarker; CDT; Ethyl glucuronide; Glycoforms; HPLC; Human serum transferrin

Indexed keywords

ANTICONVULSIVE AGENT; C REACTIVE PROTEIN; CARBOHYDRATE DEFICIENT TRANSFERRIN; DISIALOTRANSFERRIN; ETHYL GLUCURONIDE; GLUCURONIDE; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ALCOHOL DRINKING; ANTICONVULSANTS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIABETES MELLITUS, TYPE 2; FALSE POSITIVE REACTIONS; HUMANS; TRANSFERRIN;

HEPATITIS C VIRUS;

EID: 38649136942     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.11.020     Document Type: Article

References (20)

1. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37 (1991) 2029-2037
2. Helander A., Eriksson G., Stibler H., and Jeppsson J.-O. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 47 (2001) 1225-1233
3. Fleming M.F., Anton R.F., and Spies C.D. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res 28 (2004) 1347-1355
4. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 47 (2001) 13-27
5. Helander A., Husa A., and Jeppsson J.-O. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 49 (2003) 1881-1890
6. Jeppsson J.-O., Arndt T., Schellenberg F., et al. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 45 (2007) 558-562
7. Fagerberg B., Agewall S., Urbanavicius V., Attvall S., Lundberg P.A., and Lindstedt G. Carbohydrate-deficient transferrin is associated with insulin sensitivity in hypertensive men. J Clin Endocrinol Metab 79 (1994) 712-715
8. Jensen P.D., Peterslund N.A., Poulsen J.H., Jensen F.T., Christensen T., and Ellegaard J. The effect of iron overload and iron reductive treatment on the serum concentration of carbohydrate-deficient transferrin. Br J Haematol 88 (1994) 56-63
9. Bean P., Sutphin M.S., Liu Y., et al. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin Chem 41 (1995) 858-861
10. Larsson A., Flodin M., and Kollberg H. Increased serum concentrations of carbohydrate-deficient transferrin (CDT) in patients with cystic fibrosis. Ups J Med Sci 103 (1998) 231-236
11. Bråthen G., Bjerve K.S., Brodtkorb E., and Bovim G. Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures. J Neurol Neurosurg Psychiatry 68 (2000) 342-348
12. DiMartini A., Day N., Lane T., Beisler A.T., Dew M.A., and Anton R. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res 25 (2001) 1729-1733
13. Piagnerelli M., Boudjeltia K.Z., Nuyens V., et al. Rapid alterations in transferrin sialylation during sepsis. Shock 24 (2005) 48-52
14. Fleming M., and Mundt M. Carbohydrate-deficient transferrin: validity of a new alcohol biomarker in a sample of patients with diabetes and hypertension. J Am Board Fam Pract 17 (2004) 247-255
15. Høiseth G., Bernard J.P., Karinen R., et al. A pharmacokinetic study of ethyl glucuronide in blood and urine: applications to forensic toxicology. Forensic Sci Int 172 (2007) 119-124
16. Arndt T., Meier U., Nauck M., and Gressner A.M. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: experience with four independent CDT analysis methods. Clin Chim Acta 372 (2006) 184-187
17. Helander A. Absolute or relative measurement of carbohydrate-deficient transferrin in serum? Experiences with three immunological assays. Clin Chem 45 (1999) 131-135
18. Sorvajärvi K., Blake J.E., Israel Y., and Niemelä O. Sensitivity and specificity of carbohydrate-deficient transferrin as a marker of alcohol abuse are significantly influenced by alterations in serum transferrin: comparison of two methods. Alcohol Clin Exp Res 20 (1996) 449-454
19. De Feo T.M., Fargion S., Duca L., et al. Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology 29 (1999) 658-663
20. Bergström J.P., and Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta (2007) 10.1016/j.cca.2007.10.011